Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | EB-VST cells |
Synonyms | |
Therapy Description |
EBV specific T (EB-VST) cells are cytotoxic T-cells that recognize cells containing Epstein-Barr Virus specific antigens, potentially resulting in increased death of EBV-associated tumor cells (PMID: 26807226, PMID: 26428384). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
EB-VST cells | EBV-specific T cells|EBV-CT | EBV specific T (EB-VST) cells are cytotoxic T-cells that recognize cells containing Epstein-Barr Virus specific antigens, potentially resulting in increased death of EBV-associated tumor cells (PMID: 26807226, PMID: 26428384). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT01498484 | Phase II | EB-VST cells | Therapeutic Effects of Epstein-Barr Virus Immune T-Lymphocytes Derived From a Normal HLA-Compatible Or Partially-Matched Third-Party Donor in the Treatment of EBV Lymphoproliferative Disorders and EBV-Associated Malignancies | Completed | USA | 0 |